Our latest insights

What We're Thinking

When a rare disease enters your household you have to take drastic measures, but why not have fun while doing it? Mix Talent's KC McAllister discusses the ups and downs with a first-hand experiencer: Ryan Sheedy. Sheedy is a father of a Costello's Syndrome patient, funny guy on his Instagram @dadhappend and founder of mejo, an online tool that helps caregivers organize medical information to create a personal health journal specifically tailored to their child.

When living with a rare disease, it would be easy to cope and become resigned to your fate, but this Mix Tape episode is about living fearlessly! Today, Mix Talent recruiter Emma Borreggine talks with Justin Borreggine, co-founder of DEFY Foundation. DEFY is a non-profit organization dedicated to raising awareness and research funding for Vascular Ehlers-Danlos Syndrome, or VEDS.

Mix Talent is recognizing Rare Disease Day 2022 by celebrating rare heroes from across the country whose initiative, advocacy, and perseverance are making a difference in the lives of others.

There's a difference between basic compliance and creating a diverse culture. Mix Talent's Amy Akillian takes this episode to talk to an expert in building diversity into businesses: Ryan MacLean. MacLean is the Executive Director and Head of HR for Commercial & Operations in Vertex Pharmaceuticals.

When COVID-19 struck the United States, Mix Talent was partnered with two clients building field sales teams in preparation for launch and expansion. We had 5 hiring events scheduled across the country for 375 candidates over a two-week period. As travel restrictions and quarantines were issued, we needed to quickly identify solutions to keep timelines, meet their business needs and maintain the safety of all.

With an ever changing science industry, the need for multidisciplinary scientists is growing. Today, Mix Talent's Drew Rothschild talks to drug-development-expert-now-CEO-AND-CSO Jan Rosenbaum, a living example of how successful integrating multiple industry skills can be. Rosenbaum is the President, CEO, and CSO of Kurome Therapeutics, a Cincinnati based company that targets therapies for adaptive resistance in cancer cells.

Scroll to Top